Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yang Qian, Chenting Cai, Mengqing Sun, Dan Lv & Yun Zhao. (2023) Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2707-2723.
Read now
Read now
Lihua Huang, Zhanpeng Lu, Xiaoqing Zhou, Liuliu He, Xiaoyan You, Chunmei Chen & Chunsheng Zou. (2023) U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 305-316.
Read now
Read now
Maaike C. Zuur-Telgen, Emanuel Citgez, Abraham T. Zuur, Paul VanderValk, Job van der Palen, Huib A. M. Kerstjens & Marjolein Brusse-Keizer. (2021) Predicting Mortality in COPD with Validated and Sensitive Biomarkers; Fibrinogen and Mid-Range-Proadrenomedullin (MR-proADM). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 643-649.
Read now
Read now
Ji-Yong Moon, Fernando Sergio Leitao Filho, Kimeya Shahangian, Hiroto Takiguchi & Don D. Sin. (2018) Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD). Expert Review of Proteomics 15:11, pages 923-935.
Read now
Read now
Joanna Miłkowska-Dymanowska, Adam J Białas, Anna Zalewska-Janowska, Paweł Górski & Wojciech J Piotrowski. (2015) Underrecognized comorbidities of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1331-1341.
Read now
Read now
Dennis B. Holmgaard, Lone H. Mygind, Ingrid Titlestad, Hanne Madsen, Svend Stenvang Pedersen, Ole H. Mortensen & Court Pedersen. (2013) Calprotectin — A Marker of Mortality in COPD? Results from a Prospective Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:5, pages 581-587.
Read now
Read now
Robert P Young & Raewyn J Hopkins. (2013) Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities. Expert Review of Respiratory Medicine 7:5, pages 533-544.
Read now
Read now
Articles from other publishers (27)
Sunil A. Kumar, K Rakul Nambiar & A Ravikumar Kurup. (2022) Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease. The Indian Journal of Chest Diseases and Allied Sciences 60:4, pages 233-237.
Crossref
Crossref
静静 谢. (2022) Research Progress of Fibrinogen/Prealbumin in the Diagnosis and Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Advances in Clinical Medicine 12:12, pages 11031-11036.
Crossref
Crossref
Trishul Siddharthan, Suzanne L. Pollard, Peter Jackson, Nicole M. Robertson, Adaeze C. Wosu, Nihaal Rahman, Roma Padalkar, Isaac Sekitoleko, Esther Namazzi, Patricia Alupo, John R. Hurst, Robert Kalyesubula, David Dowdy, Robert Wise, Peter J. Barnes, William Checkley & Bruce Kirenga. (2021) Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial. Trials 22:1.
Crossref
Crossref
Camila Thais Adam, Ione Jayce Ceola Schneider, Danielle Soares Rocha Vieira, Tauana Prestes Schmidt, Fernando Cesar Wehrmeister & Cesar de Oliveira. (2021) Are elevated plasma fibrinogen associated with lung function? An 8-year follow-up of the ELSA study. PLOS ONE 16:11, pages e0259498.
Crossref
Crossref
Kashifa Ehsan, Sibgha Zulfiqar, Amber Hassan & Humaira Waseem. (2021) Plasma Fibrinogen as a Biomarker of Stable and Exacerbated Chronic Obstructive Pulmonary Disease. The Open Biomarkers Journal 11:1, pages 48-53.
Crossref
Crossref
Gunnar R. Husebø, Esteban C. Gabazza, Corina D'Alessandro Gabazza, Taro Yasuma, Masaaki Toda, Marianne Aanerud, Rune Nielsen, Per S. Bakke & Tomas M.L. Eagan. (2020)
Coagulation markers as predictors for clinical events in
COPD
. Respirology 26:4, pages 342-351.
Crossref
Crossref
Bo Zhou, Shufang Liu, Danni He, Kundi Wang, Yunfeng Wang, Ting Yang, Qi Zhang, Zhixin Zhang & Wenquan Niu. (2020) Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis. Bioscience Reports 40:7.
Crossref
Crossref
Jilles M Fermont, Katya L Masconi, Magnus T Jensen, Renata Ferrari, Valéria A P Di Lorenzo, Jacob M Marott, Philipp Schuetz, Henrik Watz, Benjamin Waschki, Hana Müllerova, Michael I Polkey, Ian B Wilkinson & Angela M Wood. (2019) Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis. Thorax 74:5, pages 439-446.
Crossref
Crossref
Tian‐Lai Lin, Wei‐Wen Chen, Zhi‐Rong Ding, Si‐Can Wei, Ming‐Lian Huang & Cai‐Hui Li. (2019) Correlations between serum amyloid A, C‐reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease. Journal of Clinical Laboratory Analysis 33:4, pages e22831.
Crossref
Crossref
Derek W. Russell & Amit Gaggar. (2018) ADAM9: A Damaging Player in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 198:12, pages 1465-1466.
Crossref
Crossref
Eric Bradford, Sean Jacobson, Jason Varasteh, Alejandro P. Comellas, Prescott Woodruff, Wanda O’Neal, Dawn L. DeMeo, Xingnan Li, Victor Kim, Michael Cho, Peter J. Castaldi, Craig Hersh, Edwin K. Silverman, James D. Crapo, Katerina Kechris & Russell P. Bowler. (2017) The value of blood cytokines and chemokines in assessing COPD. Respiratory Research 18:1.
Crossref
Crossref
Rachel L. Zemans, Sean Jacobson, Jason Keene, Katerina Kechris, Bruce E. Miller, Ruth Tal-Singer & Russell P. Bowler. (2017) Multiple biomarkers predict disease severity, progression and mortality in COPD. Respiratory Research 18:1.
Crossref
Crossref
Anne Kaul, Sven Gläser, Anke Hannemann, Beate Stubbe, Stefan B. Felix, Matthias Nauck, Ralf Ewert & Nele Friedrich. (2017) No mediating effects of glycemic control and inflammation on the association between vitamin D and lung function in the general population. Respiratory Medicine 125, pages 1-7.
Crossref
Crossref
Hyeon-Kyoung KooHyung Koo KangPamela SongHye Kyeong ParkSung-Soon LeeHoon Jung. (2017) Systemic White Blood Cell Count as a Biomarker Associated with Severity of Chronic Obstructive Lung Disease. Tuberculosis and Respiratory Diseases 80:3, pages 304.
Crossref
Crossref
Andrew J. Sedgewick, Ivy Shi, Rory M. Donovan & Panayiotis V. Benos. (2016) Learning mixed graphical models with separate sparsity parameters and stability-based model selection. BMC Bioinformatics 17:S5.
Crossref
Crossref
Derek W. Russell, J. Michael Wells & J. Edwin Blalock. (2016) Disease phenotyping in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 22:2, pages 91-99.
Crossref
Crossref
Puja Kohli, Victor Pinto-Plata, Miguel Divo, Atul Malhotra, R. Scott Harris, Aili Lazaar, Aiden Flynn, Ruth Tal-Singer, Reynold A. Panettieri & Bartolome Celli. (2015) Functional Capacity, Health Status, and Inflammatory Biomarker Profile in a Cohort of Patients With Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation and Prevention 35:5, pages 348-355.
Crossref
Crossref
Earl S. Ford, Timothy J. Cunningham & David M. Mannino. (2015) Inflammatory markers and mortality among US adults with obstructive lung function. Respirology 20:4, pages 587-593.
Crossref
Crossref
Hana Müllerova, Diego J. Maselli, Nicholas Locantore, Jørgen Vestbo, John R. Hurst, Jadwiga A. Wedzicha, Per Bakke, Alvar Agusti & Antonio Anzueto. (2015) Hospitalized Exacerbations of COPD. Chest 147:4, pages 999-1007.
Crossref
Crossref
Sofie Lock-Johansson, Jørgen Vestbo & Grith Lykke Sorensen. (2014) Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respiratory Research 15:1.
Crossref
Crossref
Daiana Stolz, Anja Meyer, Janko Rakic, Lucas Boeck, Andreas Scherr & Michael Tamm. (2014) Mortality risk prediction in COPD by a prognostic biomarker panel. European Respiratory Journal 44:6, pages 1557-1570.
Crossref
Crossref
Mona Fattouh & Ola Alkady. (2014) Inflammatory biomarkers in chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis 63:4, pages 799-804.
Crossref
Crossref
Etheresia Pretorius & Douglas B. Kell. (2014) Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr. Biol. 6:5, pages 486-510.
Crossref
Crossref
Antje Kuhlmann, Inga Sif Ólafsdóttir, Lars Lind, Johan Sundström & Christer Janson. (2013) Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study. BMC Geriatrics 13:1.
Crossref
Crossref
Jessica Bon, Serena Liao, George Tseng & Frank C. Sciurba. (2013) Considerations and pitfalls in phenotyping and reclassification of chronic obstructive pulmonary disease. Translational Research 162:4, pages 252-257.
Crossref
Crossref
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli, Meredith C. McCormack, Eric Peng, Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory B. Diette & Nadia N. Hansel. (2013) Effects of Allergic Phenotype on Respiratory Symptoms and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 188:2, pages 187-192.
Crossref
Crossref
Benjamin L. Nicholas. (2013) Search for biomarkers in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 19:2, pages 103-108.
Crossref
Crossref